- Brand: Bevespi AerosphereGeneric: Glycopyrrolate and Formoterol Fumarate Inhalation Aerosol
- Brand: Breztri AerosphereGeneric: Budesonide, Glycopyrrolate, and Formoterol Fumarate Inhalation Aerosol
- Brand: BrovanaGeneric: Arformoterol Tartrate Inhalation Solution
- Brand: Duaklir PressairGeneric: Aclidinium Bromide and Formoterol Fumarate Inhalation Powder
- Brand: DuleraGeneric: Mometasone Furoate, Formoterol Fumarate Dihydrate Inhalation
- Brand: Foradil AerolizerGeneric: Formoterol Fumarate Inhalation Powder
- Brand: Foradil CertihalerGeneric: Formoterol Fumarate Inhalation Powder
- Brand: PerforomistGeneric: Formoterol Fumarate Inhalation Solution
- Brand: SymbicortGeneric: Budesonide and Formoterol Fumarate Dihydrate
- Brand: Asmanex TwisthalerGeneric: Mometasone Furoate
- Brand: Advair HFAGeneric: Fluticasone Propionate and Salmeterol
- Brand: AirDuo RespiClick Inhalation PowderGeneric: Fluticasone Propionate and Salmeterol
- Brand: Breo ElliptaGeneric: Fluticasone Furoate and Vilanterol Inhalation Powder
- Brand: Wixela InhubGeneric: Fluticasone Propionate and Salmeterol Inhalation Powder
Diseases, Conditions, and Procedures
- Asthma MedicationsSource: MedicineNet
Learn about various asthma medications, including short-term control, rescue drugs like inhalers, OTC medications, and long-term controllers. Discover potential asthma medication side effects, plus, learn which asthma drugs are appropriate for toddlers, children, and pregnant women.
- Chronic BronchitisSource: MedicineNet
Chronic bronchitis is different from acute bronchitis in that it involves a cough that lasts for at least 3 months, 2 years in a row. Signs and symptoms are cough and sputum production (the most common symptoms), wheezing, shortness of breath, and fatigue.
- Emphysema Source: MedicineNet
Emphysema is a condition that is considered a type of COPD. Emphysema usually occurs with chronic bronchitis. The most common cause of emphysema is long-term cigarette smoking. Learn about treatment, 4 stages, causes, symptoms, life expectancy, and prevention.
- COPD vs. Asthma (Differences and Similarities)Source: MedicineNet
COPD, or chronic obstructive pulmonary disease, and asthma are two respiratory diseases. COPD is caused by smoking, and asthma is caused by your genes and how they interact with your environment. Similar symptoms between the two diseases include a feeling of tightness in the chest, shortness of breath, cough, and wheezing. Neither condition can be cured, and a person with COPD has a poorer prognosis than asthma.
- AsthmaSource: MedicineNet
Read about asthma attacks and asthma treatment, types, medications, symptoms, triggers, causes, and prevention. Asthma is chronic airway inflammation marked by recurrent airway obstruction.
- COPD (Chronic Obstructive Pulmonary Disease) Source: MedicineNet
COPD stands for "chronic obstructive pulmonary disease" and is a chronic lung condition in which airflow into and out of the lungs slowly and progressively becomes obstructed. Symptoms of COPD are shortness of breath and chronic cough. The life expectancy for a person with COPD depends upon the stage of the disease. Treatment for COPD depends upon the person's health and stage of the disease.
- Asthma Drug Symbicort OK for COPDSource: WebMD Health News
Learn more about Symbicort, which is an asthma drug the FDA just approved to treat chronic obstructive pulmonary disease (COPD).
- Asthma Drug May Be Fat-Burner PillSource: WebMD Health News
According to new research, a medicine used to treat asthma may also be a fat-burning drug.
- FDA Clears Bevespi Aerosphere for COPDSource: RxList
The US Food and Drug Administration (FDA) has approved the first long-acting muscarinic antagonist/long-acting beta-2 agonist combination in a pressurized metered-dose inhaler (pMDI), using novel co-suspension technology for chronic obstructive pulmonary disease (COPD), according to an AstraZeneca release.
- FDA OKs Symbicort for Uncontrolled Asthma in Kids 6 to 12Source: WebMD Health News
The US Food and Drug Administration has approved AstraZeneca's Symbicort inhalation aerosol (80/4.5 mcg) for children aged 6 to 12 years with asthma that is not well controlled with an inhaled corticosteroid, the company has announced.